• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Array BioPharma Inc

+ Add to Watchlist

ARRY:US

3.7600 USD 0.0300 0.79%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Array BioPharma Inc (ARRY)

Open: 3.8000 Day's Range: 3.6900 - 3.9000 Volume: 2,823,869
Previous Close: 3.7900 52wk Range: 3.3900 - 6.6600 1-Yr Rtn: -41.16%

Stock Chart for ARRY

No chart data available.
  • ARRY:US 3.7450
  • 1D
  • 1M
  • 1Y
3.7900
Interactive ARRY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARRY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6679
Est. EPS (USD) (06/2015) -0.7870
Est. PEG Ratio -
Market Cap (M USD) 495.67
Shares Outstanding (M) 131.83
30 Day Average Volume 1,233,799
Price/Book (mrq) -
Price/Sale (ttm) 10.9322
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARRY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARRY

Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

Ron SquarerChief Executive OfficerVictor SandorChief Medical Officer
R Michael CarruthersChief Financial OfficerNicholas A SaccomanoChief Scientific Officer
More Company Profile & Key Executives for ARRY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil